Abstract 617: High-throughput screens identify PARP inhibition as being synthetically lethal with ERCC1 deficiency in non-small cell lung cancer cell lines.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol Volume 10
◽
pp. 1921-1932
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):